AMGN - Bristol Myers Squibb: The More It Drops The More I Buy

2024-07-16 08:10:00 ET

Summary

• Stock market investing is not a zero-sum game, offering long-term potential for growth and income when it comes to highly undervalued stocks.
• Bristol Myers Squibb stock is undervalued, with strong revenue growth, profitability, and a promising drug pipeline.
• BMY presents a high conviction buy opportunity for value and income investors, with potential for future growth and acquisitions.

Stock market investing is sometimes referred to as a giant casino, in which day to day price movements are hard to predict, due to the multitude of variables and external events that can influence prices....

For further details see: